Page last updated: 2024-10-29

ketanserin and Lung Neoplasms

ketanserin has been researched along with Lung Neoplasms in 2 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Lung Neoplasms: Tumors or cancer of the LUNG.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drozdov, I1
Kidd, M1
Gustafsson, BI1
Svejda, B1
Joseph, R1
Pfragner, R1
Modlin, IM1
Skolnik, G1
Ivarsson, L1
Bagge, U1

Other Studies

2 other studies available for ketanserin and Lung Neoplasms

ArticleYear
Autoregulatory effects of serotonin on proliferation and signaling pathways in lung and small intestine neuroendocrine tumor cell lines.
    Cancer, 2009, Nov-01, Volume: 115, Issue:21

    Topics: Cell Line, Tumor; Cell Proliferation; Homeostasis; Humans; Intestinal Neoplasms; JNK Mitogen-Activat

2009
The influence of antiserotonin treatment with ketanserin on the pulmonary lodgement of circulating tumour cells in normal and traumatized rats.
    European journal of cancer & clinical oncology, 1983, Volume: 19, Issue:6

    Topics: Animals; Femoral Fractures; Fibrosarcoma; Ketanserin; Lung Neoplasms; Neoplasm Transplantation; Neop

1983